Zydus Lifesciences Ltd (ZYDUSLIFE) Stock Price & News

ZYDUSLIFE:NSE

Zydus Lifesciences Ltd

₹1,245.50

+5.16%

(+61.10) 1D

Oct 30, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Next call in 3 days

Wed, Nov 4, 5:00 AM

Fiscal period

Q2 2027

- / ₹8.78

Revenue / Est. (INR)

- / 75.88B

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	61.23B	68.64B	75.87B	80.17B
Cost of goods sold	16.90B	18.36B	22.07B	22.40B
Cost of revenue	16.90B	18.36B	22.07B	22.40B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	10.34B	11.40B	32.92B	13.68B
Operating expense	31.33B	37.36B	39.40B	44.59B
Total operating expenses	48.23B	55.72B	61.48B	66.99B
Operating income	13.00B	12.92B	14.39B	13.18B
Other non operating income	1.09B	1.11B	-3.70B	1.06B
EBT including unusual items	16.93B	14.11B	16.59B	13.44B
EBT excluding unusual items	17.27B	14.96B	20.88B	13.63B
Income tax expense	4.54B	3.88B	3.18B	3.54B
Effective tax rate	26.82%	27.52%	19.19%	26.35%
Other operating expenses	17.97B	22.36B	1.28B	25.36B
Net income	12.59B	10.42B	12.72B	9.40B
Net profit margin	20.55%	15.18%	16.77%	11.72%
Earnings per share	12.76	10.96	15.84	9.48
Interest and investment income	-	-	4.24B	-
Interest expense	-1.01B	-1.30B	-491.00M	-1.56B
Net interest expenses	-1.01B	-1.30B	3.75B	-1.56B
Depreciation and amortization charges	3.02B	3.60B	5.08B	5.55B
EBITDA	15.70B	15.10B	17.74B	16.53B
Gain or loss from assets sale	-	-	-	-

Finance